
Vivos Inc.
OTC:RDGL
Overview | Financials
Company Name | Vivos Inc. |
Symbol | RDGL |
Currency | USD |
Price | 0.054 |
Market Cap | 20,157,486 |
Dividend Yield | 0% |
52-week-range | 0.04 - 0.12 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Michael K. Korenko Ph.D. |
Website | https://www.radiogel.com |
An error occurred while fetching data.
About Vivos Inc.
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD